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refrained from further evaluating MESs detected during other
operation stages. Our study thus can provide no information on the
relation between MES counts and various stages of cardiac surgery or
surgical manipulations, because the MESs detected in this study were
not caused by surgical interventions but solely by the oxygenator.
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Should HIV-positive recipients undergo heart transplantation?
Gianluigi Bisleri, MD, Jeffrey A. Morgan, MD, Mario C. Deng, MD, Donna M. Mancini, MD, and Mehmet C. Oz, MD,
New York, NY
Several centers have reported successful midterm resultsin HIV-positive patients who have undergone solid-or-gan transplantation.1,2 These reports have generally beenlimited to hepatic and renal transplantation. However,
Calabrese and colleagues3 recently described a case of an HIV-
positive patient who underwent successful orthotopic cardiac
transplantation with midterm follow-up. The aim of this report is
to describe another case of successful cardiac transplantation in an
HIV-positive patient.
Clinical Summary
Our patient was a 42-year-old man with a 4-year history of HIV
without any previous opportunistic infections. The patient had
idiopathic cardiomyopathy with an ejection fraction of 10% and a
history of multiple admissions for New York Heart Association
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TABLE 1. MES counts detected in 11 patients during cardiopulmonary bypass
Case
Age
(y) Sex Bypass time (min)
MES counts
Before filter After filter
Right
MCA
Left
MCA
Both
MCAs
1 69 F 70 9258 6768 8 6 14
2 44 M 67 5458 3469 97 148 245
3 15 M 65 6569 4610 462 389 851
4 56 M 72 7933 4643 530 157 687
5 70 F 60 17,564 8091 160 126 286
6 73 M 75 4395 2363 23 29 52
7 60 M 68 1683 1323 12 24 36
8 66 M 79 5315 1868 73 54 127
9 49 F 64 8088 2678 28 52 80
10 78 M 55 26,230 18,458 31 15 46
11 72 F 110 7901 4861 102 98 200
Total
Sum 100,394 59,132 1526 1098 2624
Median 7343 4588 85 81 163
95% Confidence interval 4927-15,132 2668-9890 26-279 29-197 52-452
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class IV heart failure, which were treated with intravenous milri-
none. During this time period, his viral load was undetectable, and
his absolute CD4 count was 40% to 100% of normal values
(596-1140/L).
The patient underwent an unremarkable orthotopic heart trans-
plantation and was discharged on postoperative day 9. It is now 2
years after his transplantation, and he has since not developed any
opportunistic infections, has returned to work, and is maintained
on lamivudine (Epivir), viread (Tenofovir), and viramune (Nevi-
rapine) in addition to low-dose standard immunosuppressants.
Over the 2-year follow-up period, the patient had one episode
of focal acute rejection (International Society for Heart and Lung
Transplantation grade 2). Serial HIV-1 blood quantification con-
tinues to demonstrate an undetectable viral load (ie, 50 copies of
HIV-1 RNA per milliliter of plasma). The patient’s CD4 cell count
has remained at 650 to 1000/L.
Discussion
Since the introduction of more effective treatment options for HIV,
such as protease inhibitors and antiretroviral therapy, the life
expectancy of patients with HIV has significantly improved.4-6 As
a consequence, an increasing number of HIV-positive patients are
presenting with manifestations of end-stage organ dysfunction,
such as cardiomyopathy.4 To date, there have been several reports
of successful liver and kidney transplantation in HIV-positive
patients (Table 1).1,2,5,6 More recently, a case report described
successful heart transplantation in a patient with a 10-year history
of HIV, multiple previous opportunistic infections, and Kaposi
sarcoma.3
The patient in our report had a very different preoperative
clinical profile. Our patient had an undetectable viral load, normal
CD4 count, and no history of opportunistic infections. This is
consistent with the patient profiles that have been described in
previous reports of successful liver and kidney transplantation in
HIV-positive patients.1,2 It is our opinion that the presence of HIV
disease in and of itself should not serve as a contraindication for
heart transplantation. Cardiac transplantation might be a therapeu-
tic option in carefully selected patients with HIV. A careful pre-
operative evaluation of each HIV-positive patient is warranted. We
are not advocating indiscriminate transplantation of patients with
HIV. Given the limited experience with transplantation in these
patients, we believe that cardiac transplantation should be reserved
for only those HIV-positive patients with undetectable viral loads,
normal CD4 counts, and no history of opportunistic infections. In
this subset of patients, it is possible that survival might be similar
to that of patients without HIV. It is important for single centers to
report their transplant experience in HIV-positive patients. How-
ever, study of more patients with longer follow-up periods is
necessary before definitive statements regarding their outcome and
allocation of scarce resources can be made.
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TABLE 1. Review of literature on solid-organ transplanta-
tion in HIV recipients
Reference
Transplants
(n) Organ
Alive at
follow-up
(%)
Mean
follow-up
time (y)
Tzakis and associates5 11 7 livers 28 1.8
3 kidneys 100 3.8
1 heart 100 2.1
Ragni and colleagues6 1 Liver 100 0.5
Roland and Stock1 45 26 kidneys 92 0.8
19 livers 79 0.8
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